Skip to main content
Bioera logo

Bioera — Investor Relations & Filings

Ticker · BIE ISIN · IT0005516130 LEI · 815600CE609AFE44D992 XMIL Manufacturing
Open in API
Filings indexed 558 across all filing types
Latest filing 2021-03-25 Share Issue/Capital Cha…
Country IT Italy
Listing XMIL BIE

About Bioera

https://bioera.it/en/

Bioera S.p.A. is a company specializing in the production and distribution of natural and organic products. Its core business involves the development and marketing of a diverse portfolio that includes organic food, traditional food products, natural cosmetics, herbal remedies, and food supplements. The company focuses on providing consumers with products derived from natural sources, catering to the health and wellness market.

Recent filings

Filing Released Lang Actions
Bioera S.p.A. - Richiesta di conversione Warrant A
Share Issue/Capital Change Classification · 1% confidence The document is a formal announcement from Bioera S.p.A. dated March 25, 2021, regarding the 'Richiesta di conversione di n. 462.536 Warrant A' (Request for conversion of 462,536 Warrant A). It details the issuance of new shares and new Warrant B in exchange for the converted Warrant A, specifying the exercise price and the resulting change in the total number of outstanding shares. This clearly relates to a change in the company's capital structure due to the exercise of warrants, which falls under the definition of Capital/Financing Update (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), but a specific corporate action related to financing instruments.
2021-03-25 Italian
Bioera S.p.A. - Richiesta di conversione Warrant A
Capital/Financing Update Classification · 1% confidence The document is a formal announcement from Bioera S.p.A. dated March 22, 2021, regarding the receipt of a request for the conversion of 462,536 'Warrant A' into new ordinary shares and 'Warrant B'. This action directly involves changes to the company's capital structure (issuance of new shares and warrants) resulting from the exercise of convertible instruments. This fits the definition of 'Capital/Financing Update' (CAP) as it details a financing/capital structure change event, specifically the conversion of warrants into equity. Although it involves shares, it is not a general share issue announcement (SHA) but a specific financing instrument conversion outcome. It is not an earnings release, an annual report, or a management discussion, but a specific corporate action related to financing instruments.
2021-03-22 Italian
Bioera S.p.A. - Comunicazione di variazione del capitale sociale
Share Issue/Capital Change Classification · 1% confidence The document is an official communication ('Comunicazione di variazione del capitale sociale') from Bioera S.p.A. dated March 22, 2021. It details the change in the total number of shares following the conversion of warrants. The key subject is the change in the company's capital structure (share count and total capital in Euro). This directly corresponds to the definition of 'Share Issue/Capital Change' (SHA), which covers changes in capital structure, including those resulting from warrant conversions.
2021-03-22 Italian
Bioera S.p.A. - Richiesta di conversione Warrant A
Capital/Financing Update Classification · 1% confidence The document is a formal announcement from Bioera S.p.A. regarding the conversion of warrants into new ordinary shares. The subject line explicitly states: 'Richiesta di conversione Warrant A' (Request for conversion of Warrant A). This action directly impacts the company's capital structure by issuing new shares and warrants (Warrant B) in exchange for the cancellation of existing warrants (Warrant A). This falls under the category of financing activities or capital structure changes. The most appropriate classification among the provided options is 'Capital/Financing Update' (CAP), as it details the issuance of new shares resulting from a financing instrument conversion.
2021-03-15 Italian
Bioera S.p.A. - Richiesta di conversione Warrant A
Share Issue/Capital Change Classification · 1% confidence The document is a formal announcement from Bioera S.p.A. regarding the conversion of warrants into new ordinary shares. The subject line explicitly states: 'Richiesta di conversione Warrant A' (Request for conversion of Warrant A). This action directly impacts the company's capital structure by issuing new shares and warrants (Warrant B) in exchange for the cancellation of existing warrants (Warrant A). This falls under the category of financing activities or capital structure changes. The most appropriate classification among the provided options is 'Capital/Financing Update' (CAP), as it details the issuance of new shares resulting from a financing instrument conversion.
2021-03-15 Italian
Bioera S.p.A. - Richiesta di conversione Warrant A
Share Issue/Capital Change Classification · 1% confidence The document is a formal announcement from Bioera S.p.A. regarding a specific corporate action: the conversion of warrants (Warrant A) into new ordinary shares and new warrants (Warrant B). The subject line explicitly states 'Richiesta di conversione di n. 443.262 Warrant A' (Request for conversion of n. 443,262 Warrant A). This action directly relates to changes in the company's capital structure and financing instruments. Based on the definitions, this falls under 'Capital/Financing Update' (CAP), as it details the issuance of new shares resulting from a warrant conversion, which is a form of capital restructuring/financing activity. It is not an earnings release (ER), an interim report (IR), or a general regulatory filing (RNS), as it concerns a specific capital event.
2021-03-08 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.